+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Small Animal Imaging (In-Vivo) - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140277
The global market for Small Animal Imaging (In-Vivo) was valued at US$3.1 Billion in 2024 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Small Animal Imaging (In-Vivo) market.

Global Small Animal Imaging (In-Vivo) Market - Key Trends and Drivers Summarized

Why Is Small Animal Imaging Essential for Preclinical Studies?

Small animal imaging (in-vivo) is crucial for preclinical studies as it provides non-invasive, high-resolution imaging solutions for monitoring biological processes in live animals. This technology is extensively used in drug development, cancer research, cardiovascular studies, and neuroscience to assess disease progression, therapeutic efficacy, and pharmacokinetics. Small animal imaging techniques, such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Computed Tomography (CT), offer real-time, longitudinal, and quantitative data, enhancing the reliability and translational value of preclinical research. The increasing focus on personalized medicine, targeted therapies, and molecular imaging is driving the adoption of small animal imaging systems across research institutions, pharmaceutical companies, and academic laboratories.

How Are Technological Advancements Enhancing Small Animal Imaging?

Technological advancements are enhancing small animal imaging by integrating multi-modal, hybrid, and AI-driven imaging systems that provide comprehensive insights into biological processes. The development of multi-modal imaging systems combining MRI, PET, SPECT, and CT modalities is enabling researchers to capture multiple data points simultaneously, improving the accuracy and depth of preclinical studies. Innovations in AI-based image analysis, deep learning algorithms, and data management systems are facilitating automated, high-throughput, and quantitative analysis of imaging data, reducing the time and complexity of preclinical workflows. Furthermore, the emergence of portable, compact, and user-friendly imaging systems is expanding the accessibility of advanced imaging technologies to small and mid-sized research labs, enhancing collaboration and knowledge sharing.

Which Market Segments Are Leading the Adoption of Small Animal Imaging?

Imaging modalities include micro-MRI, PET, SPECT, CT, optical imaging (bioluminescence and fluorescence), and ultrasound, with optical imaging and PET leading the market due to their high sensitivity, specificity, and real-time imaging capabilities. Use case encompass oncology, neurology, cardiology, infectious diseases, and immunology, with oncology being the largest segment due to the high prevalence of cancer research and drug development studies. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations (CROs), with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for small animal imaging due to advanced research infrastructure, while Asia-Pacific is emerging as a high-growth region driven by increasing investments in life sciences, expanding R&D activities, and growing focus on precision medicine.

What Are the Key Drivers of Growth in the Small Animal Imaging Market?

The growth in the small animal imaging market is driven by several factors, including the rising demand for preclinical research and drug development, increasing adoption of multi-modal, hybrid, and AI-driven imaging systems, and advancements in non-invasive, high-resolution imaging technologies. The development of compact, portable, and user-friendly imaging systems is driving market adoption among academic and research institutions, pharmaceutical companies, and CROs. The growing demand for high-sensitivity, high-specificity, and real-time imaging modalities is expanding the market reach among diverse preclinical research applications. The increasing use of small animal imaging in oncology, neurology, cardiology, and immunology research, coupled with the demand for longitudinal, quantitative, and translational imaging solutions, is creating new opportunities for market growth. Additionally, the rising collaborations between research institutes, pharmaceutical companies, and imaging solution providers and the increasing investments in R&D for innovative imaging technologies are further supporting market expansion.

Report Scope

The report analyzes the Small Animal Imaging (In-Vivo) market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Application (Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies, Epigenetics); Imaging Modality (Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging, Other Imaging Modalities).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Micro-magnetic resonance imaging segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of a 8.9%. The Optical imaging segment is also set to grow at 7.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $866.8 Million in 2024, and China, forecasted to grow at an impressive 7.0% CAGR to reach $735.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Small Animal Imaging (In-Vivo) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Small Animal Imaging (In-Vivo) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Small Animal Imaging (In-Vivo) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aspect Imaging Ltd., Berthold Technologies GmbH & Co. KG, Bruker Corp., LI-COR Biosciences, Inc., Mediso Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Small Animal Imaging (In-Vivo) market report include:

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Small Animal Imaging (In-Vivo) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Non-Invasive, High-Resolution Imaging Technologies Propel Market Innovation
  • Increasing Focus on Personalized Medicine and Molecular Imaging Expands Addressable Market Opportunity
  • Integration of Multi-Modal Imaging Systems (MRI, PET, SPECT, CT) Reinforces Market Competitiveness
  • Rising Investments in Oncology, Neurology, and Cardiovascular Research Spurs Market Adoption
  • Focus on Enhancing Imaging Sensitivity, Specificity, and Quantitative Analysis Drives Market Demand
  • Emergence of AI-Driven Image Analysis and Deep Learning Algorithms in Small Animal Imaging Accelerates Market Transformation
  • Growing Use of Fluorescence, Bioluminescence, and Ultrasound Imaging in In-Vivo Studies Sustains Market Growth
  • Development of Compact, User-Friendly, and High-Throughput Imaging Systems Expands Market Reach
  • Rising Preference for Longitudinal, Real-Time, and 4D Imaging Modalities Generates New Growth Opportunities
  • Growing Application of Small Animal Imaging in Infectious Diseases, Immunology, and Regenerative Medicine Spurs Market Expansion
  • Shift Towards Hybrid Imaging Platforms, Portable Solutions, and Remote Data Analysis Supports Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Small Animal Imaging (In-Vivo) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Micro-magnetic resonance imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Micro-magnetic resonance imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Optical imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Optical imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Nuclear imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Nuclear imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Monitoring treatment response by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Monitoring treatment response by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Bio-distribution of drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Bio-distribution of drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Cancer cell detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Cancer cell detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 30: World Historic Review for Longitudinal studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 31: World 15-Year Perspective for Longitudinal studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 33: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 34: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 35: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 36: USA Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 37: USA 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 38: USA Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 39: USA Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 40: USA 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
CANADA
  • Table 41: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 43: Canada 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 44: Canada Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 45: Canada Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 46: Canada 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
JAPAN
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 47: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 49: Japan 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 52: Japan 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
CHINA
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 53: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 54: China Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 55: China 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 57: China Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 58: China 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
EUROPE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 59: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 61: Europe 15-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 64: Europe 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 65: Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 67: Europe 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
FRANCE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 68: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 69: France Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 70: France 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 71: France Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 72: France Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 73: France 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
GERMANY
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 74: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 75: Germany Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 76: Germany 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 77: Germany Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 78: Germany Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 79: Germany 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
ITALY
  • Table 80: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 81: Italy Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 82: Italy 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 83: Italy Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 84: Italy Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 85: Italy 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 86: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 87: UK Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 88: UK 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 89: UK Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 90: UK Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 91: UK 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 94: Rest of Europe 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 97: Rest of Europe 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Imaging Modality - Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 100: Asia-Pacific 15-Year Perspective for Small Animal Imaging (In-Vivo) by Imaging Modality - Percentage Breakdown of Value Sales for Micro-magnetic resonance imaging, Optical imaging, Nuclear imaging and Other Imaging Modalities for the Years 2015, 2025 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Small Animal Imaging (In-Vivo) by Application - Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 103: Asia-Pacific 15-Year Perspective for Small Animal Imaging (In-Vivo) by Application - Percentage Breakdown of Value Sales for Monitoring treatment response, Bio-distribution of drug, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics for the Years 2015, 2025 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

Table Information